Does TREPROSTINIL Cause Application site swelling? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Application site swelling have been filed in association with TREPROSTINIL (TYVASO). This represents 0.0% of all adverse event reports for TREPROSTINIL.
8
Reports of Application site swelling with TREPROSTINIL
0.0%
of all TREPROSTINIL reports
1
Deaths
3
Hospitalizations
How Dangerous Is Application site swelling From TREPROSTINIL?
Of the 8 reports, 1 (12.5%) resulted in death, 3 (37.5%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Application site swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Application site swelling?
INGENOL MEBUTATE (489)
NICOTINE (431)
SUMATRIPTAN (191)
ESTRADIOL (134)
BUPRENORPHINE (110)
DICLOFENAC (90)
ESTRADIOL\NORETHINDRONE (90)
DOCOSANOL (86)
MINOXIDIL (85)
METHYLPHENIDATE (80)
Which TREPROSTINIL Alternatives Have Lower Application site swelling Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE